[Translation] A double-blind, double-dummy, randomized, multicenter, two-arm parallel-group study to evaluate the efficacy of FLUTIFORM versus Seretide in the treatment of moderate-to-severe persistent asthma
本研究的主要目的是根据治疗第12周时,给药后2小时FEV1较基线时早晨给药前FEV1的变化,显示FLUTIFORM pMDI(2吸,每日2次)非劣效于舒利迭 pMDI(2吸,每日2次)
[Translation] The primary objective of this study is to demonstrate non-inferiority of FLUTIFORM pMDI (2 inhalations, twice daily) to seretide pMDI based on the change in FEV1 at 2 hours post-dose compared to baseline in morning pre-dose FEV1 at week 12 (2 puffs, 2 times a day)